• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎盘蛋白5与肝素之间的特异性相互作用。

Specific interaction between placental protein 5 and heparin.

作者信息

Jones G R, Davey M W, Sinosich M, Grudzinskas J G

出版信息

Clin Chim Acta. 1981 Feb 19;110(1):65-70. doi: 10.1016/0009-8981(81)90301-6.

DOI:10.1016/0009-8981(81)90301-6
PMID:7214716
Abstract

Levels of placental protein 5 (PP5) in paired serum and plasma samples obtained during the second half of pregnancy were measured by radioimmunoassay. The apparent level of PP5 was significantly higher in serum than in heparin-derived plasma. The addition of heparin to late pregnancy serum resulted in a dose-dependent decrease in the apparent PP5 concentrations, the maximal effect occurring at heparin concentrations greater than 4 U/ml. The same phenomenon was observed using purified PP5 and placental homogenate. The effect of heparin was readily reversed by the addition of protamine sulphate. The specificity of the interaction between heparin and PP5 was demonstrated by affinity chromatography with heparin as the ligand. The functional significance of these results are discussed in relation to observations on other placental proteins and proteins with affinity to heparin.

摘要

采用放射免疫分析法测定妊娠后半期采集的配对血清和血浆样本中胎盘蛋白5(PP5)的水平。血清中PP5的表观水平显著高于肝素衍生血浆中的水平。向妊娠晚期血清中添加肝素会导致表观PP5浓度呈剂量依赖性降低,在肝素浓度大于4 U/ml时出现最大效应。使用纯化的PP5和胎盘匀浆也观察到了相同的现象。添加硫酸鱼精蛋白可使肝素的作用轻易逆转。以肝素为配体的亲和层析证明了肝素与PP5之间相互作用的特异性。结合对其他胎盘蛋白和与肝素有亲和力的蛋白的观察结果,讨论了这些结果的功能意义。

相似文献

1
Specific interaction between placental protein 5 and heparin.胎盘蛋白5与肝素之间的特异性相互作用。
Clin Chim Acta. 1981 Feb 19;110(1):65-70. doi: 10.1016/0009-8981(81)90301-6.
2
Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer.妊娠晚期血清和血浆中胎盘蛋白5(PP5)的分子异质性:肝素-PP5聚合物的证据。
Clin Chim Acta. 1980 Nov 6;107(3):211-5. doi: 10.1016/0009-8981(80)90448-9.
3
Placental protein 5 (PP5) in pregnancy and malignant disease: the influence of heparin binding.胎盘蛋白5(PP5)在妊娠和恶性疾病中的作用:肝素结合的影响
Clin Chim Acta. 1982 Feb 26;119(1-2):21-9. doi: 10.1016/0009-8981(82)90401-6.
4
Placental protein 5 is related to blood coagulation and fibrinolytic systems.胎盘蛋白5与凝血和纤溶系统有关。
Life Sci. 1982 May 31;30(22):1885-91. doi: 10.1016/0024-3205(82)90468-4.
5
The influence of pergonal on in vitro production of placental protein 5 (PP5) by ovarian tumour cells.
Tumour Biol. 1985;6(3):233-42.
6
The effect of protamine on serum levels of placental protein 5 (PP5) in normal and abnormal pregnancy: a possible relation to coagulation abnormalities.鱼精蛋白对正常及异常妊娠时血清胎盘蛋白5(PP5)水平的影响:与凝血异常的可能关系
Br J Obstet Gynaecol. 1981 Apr;88(4):367-70. doi: 10.1111/j.1471-0528.1981.tb00998.x.
7
Placental protein 5 (PP5): development of a radioimmunoassay and measurement of circulating levels in normal pregnancy.胎盘蛋白5(PP5):放射免疫分析法的开发及正常妊娠中循环水平的测定
Br J Obstet Gynaecol. 1981 May;88(5):484-91. doi: 10.1111/j.1471-0528.1981.tb01021.x.
8
A method for the purification of placental protein 5 (PP5) from placental extracts.
Clin Chim Acta. 1983 Jul 15;131(3):289-94. doi: 10.1016/0009-8981(83)90098-0.
9
The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancy.正常妊娠晚期胎盘蛋白5的放射免疫测定及母血中的循环水平
Clin Chim Acta. 1979 Aug 1;95(3):509-16. doi: 10.1016/0009-8981(79)90203-1.
10
Specific interaction between placental protein 5 and thrombin.胎盘蛋白5与凝血酶之间的特异性相互作用。
Clin Chim Acta. 1981 Jul 18;114(1):75-82. doi: 10.1016/0009-8981(81)90230-8.

引用本文的文献

1
Adventures with Creatinine and eGFR - A National, International and Personal Story - AACB Roman Lecture 2014.肌酐与估算肾小球滤过率的探索——一个国家、国际及个人的故事——2014年澳大利亚临床生物化学协会罗马讲座
Clin Biochem Rev. 2015 May;36(2):75-82.
2
High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.早产患者的组织因子活性高且组织因子途径抑制物浓度低。
J Matern Fetal Neonatal Med. 2010 Jan;23(1):23-33. doi: 10.3109/14767050902994770.
3
Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
子痫前期和小于胎龄儿中的组织因子及其天然抑制剂
J Matern Fetal Neonatal Med. 2008 Dec;21(12):855-69. doi: 10.1080/14767050802361872.
4
A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.止血障碍与早产胎膜早破之间的联系:组织因子和组织因子途径抑制剂的作用。
J Matern Fetal Neonatal Med. 2008 Oct;21(10):732-44. doi: 10.1080/14767050802361807.
5
A baboon model for pregnancy-associated antigens (PAPP-A, PP5, PP14).
Arch Gynecol Obstet. 1990;247(2):53-62. doi: 10.1007/BF02390662.